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series ot CT and MR seans with target volume
and organs at risk marked on each slice by the
radiotherapist. The planner has to select the
positions ot isocentres (up to 3), collimator
diameters, number and range ot the arcs.
Additional parameters for optimization
procedure are the total dose proportions
delivered by each arc. The treatment plan
evaluation is based on the analysis ot DVHs tor
target volume and also tor organs at risk (orbits,
optical nerves, brain stem) in order to minimize
the dose and volume irradiated. It was accepted
that the dose unitormity tactor, detined as a ratio
DminlDmax within the target volume, should be not
less than 0.8, and should approach 0.9 as much
as possible.
The above-presented system of quality
control, specitying tolerance limits ot controlled
parameters, assures safe and precise dose
delivery in stereotactic radiotherapy.
58.
INFLUENCE OF TOTAL TIME OF
SURGERY AND POSTOPERATIVE
RADIOTHERAPY ON THE OUTCOME
PATIENTS WITH ADVANCED
LARYNGEAL CARCINOMA
P. Milecki, G. Stryczyńska,
A. Kruk-Zagajewska, S. Nawrocki,
E. Adamiak
Greatpoland Cancer Centre, Medical University,
Poznań.
Aim: to evaluate influence ot total time of
combined treatment on locoregional outcome of
treatment in group patients with larynx cancer.
Material/Methods: We pertormed retrospective
analysis ot 254 patients with with stage III or IV
squamous celi carcinoma ot larynx who were
treated between 1993 and 1996. There were
236 men, 18 women, median age was 56.3
years . Surgery consisted ot total laryngectomy
and electivel selective neck dissection. Patients
postoperativly were irradiated in coventional way
with total dose ot 60 Gy. We used shrinking tield
technique with lateral opposed photon tields to
tumor bed and upper-mid neck nodes.
Supraclavicular regions (Iower neck Iymph
nodes) were treated with an anterior field. Total
time ot combined treatment (trom the surgery to
the end ot radiotherapy) was an average 92
days (range, 65 - 131 days). The interval
between surgery and the beginning ot
radiotherapy was an average 45 days (range, 22
54
- 78 days) and time ot irradiation was an
average 45 day (range, 40 -74 days).
Results: Prolongation overall time of
combined treatment beyond 90 days is strongly
correlated with decreasing of locoregional
outcome of treatment (p=0.00036). Also
decreasing in outcome ot treatment was noted
when interval time between surgery and
beginning ot radiotherapy was more than 50
days (p=0.022) and when the time ot irradiation
was longer than 44 days (p=0.0026).
Conclusions: Decreasing ot total time ot
combined treatment (surgery and postoperative
radiotherapy) is crucial in patients with
advanced cancer of larynx.
59.
VERIFICATION OF THE 3-D DOSE
CALCULATlON ALGORITHM DURING
TOTAL SKIN ELECTRON IRRA-
DIATION WITH THE ROTARY-DUAL
FIELD TECHNIQUE
T. Piotrowski, J. Malicki, J. Pracz
Greatpoland Cancer Center, Medical Physics
Oepartment, Poznań, ZDAJ Świerk
Total skin electron irradiation is the commonly
used procedure in the treatment ot mycosis
fungoides. The aim ot this paper was to verity
the elaborated algorithm for dose calculation
during total skin electron irradiation with rotary-
dual fields technique (TSEI-RD).
Material and method: Authors moditied the 2-
O algorithm published by Podgorsak taking
account of dose distribution along the body
midline and doses in the body on a larger depth
than in the skin. Depth-dose tunction, beam
protile were measured in TSEI-RD conditions
(spoiler, source-skin distance SSO=350 cm,
tield size: 36 x 36 cm at 100 cm). Cylindrical
vax phantom was used to calculate and then to
measure the doses in a depth of 0.4 cm during
exposure to the electron beam ot 6 MeV (at the
output of Clinac-2300CD accelerator). Phantom
was rotating with the pre-calculated speed
during constant exposure to two tields executed
one by one in each traction. Thermoluminescent
detectors (TLD) were used tor in-phantom dose
measurements and Marcus ionization chamber
was used tor calibration ot TLD. Dose
homogeneity on the phantom surtace was
checked for three phantoms with different
diameters ot 20, 30 and 40 cm. Phantoms were
irradiated at different rotating speeds.
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Initial results: Doses measured by TLD were
on average by 4% lower than doses pre-
calculated using the modified algorithm. Mean
doses normalized to those pre-calculated and
their standard deviations (both in per cents)
were respectively: 96.1 % and 0.4 % for
phantom with diameter of 20; 96.5% and
0.7% for diameter of 30 cm and 96.0% and
0.8% for diameter of 40 cm.
Conclusions: Measured doses proved
correctness of elaborated algorithm. Very low
standard deviations are resulting from regular
cylindrical shape of the phantoms.
60.
FACTORS DETERMINING lOCAl
CONTROl IN PATIENTS (Pts) WITH
lOCAlly ADVANCED BREAST
CANCER (labe) MANAGED WITH
RADIOTHERAPY (Rt) AS THE
PRIMARY lOCOREGIONAl TREAT-
MENT
W. Rogowski1, R. DZiadziuszk01, J. Madrzak1 ,
M. Welnicka-Jaskiewicz\ Peter Barrett-Lee2,
J. Jassem1
1Medical University of Gdansk, Poland,
2Velindre NHS Trust, Cardiff, UK
Introduction: RT plays an important role in
the management of LABC, yet clinical outcomes
still remain far from satisfactory. The aim of this
study was to evaluate retrospectively factors
determining local control in a large series of
consecutive LABC pts managed with RT as the
primary locoregional treatmenł.
Material and methods: The records of 261
primarily inoperable LABC pts treated between
1991 and 1997 at two institutions: Medical
University of Gdansk, Poland and Velindre NHS
Trust, Cardiff, UK were analysed. Ali pts
received megavoltage RT to the breast with two
tangential fields, and the adjacent Iymph node
areas were irradiated using customised fields.
Due to a large scale of RT doses and
fractionation schedules, normalised total dose
(NTD) was calculated for all patients using a
linear quadratic model. In 241 pts RT constituted
the only local treatment and the remaining 20
pts were subsequently subjected to
mastectomy. Most pts received chemotherapy
and/or endocrine therapy prior or after RT.
Results: Within the median follow-up of 37
months, locoregional recurrence occurred in 95
of 251 evaluable pts (38%). Three-year and five-
year locoregional-free survival rates were 59%
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and 48%, respectively. At multivariate analysis
of variabies predicting the risk of locoregional
relapse, inflammatory carcinoma (p<0.01; RR
2.1), T4 disease (p<0.01; RR 2.9) and
involvement of supraclavicular Iymph nodes
(p<0.01; RR 2.4) were the most significant
clinical factors, whereas response to RT
(p<0.01; RR 1.2) and NTD (p<0.01; RR 0.7)
were the most important therapeutic factors.
Increasing the total dose to the tumour by 10 Gy
was associated with 30% reduction of local
relapse.
Conclusions: Due to large heterogeneity of
LABC pts, judicious tailoring of RT, particularly
in terms of dose prescribing, is essential to
increase the chance of locoregional cure.
61.
THE OUTCOMES OF THE CONVEN-
TIONALLy FRACTIONATED RADIO-
THERAPY IN THE PROSPECTIIVE
AND RETROSPRCTIVE STUDIES. IS
THE MEANING OF CONVEN-
TlONALITY THE SAME?
A.Hliniak, W. Michalski, Z. Szutkowski,
E. Kraszewska, A. Jarząbski
Centrum Onkologii, Warszawa, Polska
Aim: to discuss some problems of the
"conventionality" in the prospective and
retrospective studies finished last year at the RT
Department in Warsaw. The phase III c1inical
trial. The study was conducted according to the
evidence based rules. Cancer of the larynx -
glottis and supraglottis T1 - T3 NO MO WHO O-
1, 395 cases 196 in experimental, 199 in
conventional arm. The retrospective study
concerned all patients with the cancer of larynx
treated radically in the II department in years
1989 to May 1995. 372 patients T1- T4, N1-N3,
MO. The prospective material 150 patients were
selected [age 75 and less, WHO 0-1, T1-T3, NO,
MO] employing the same selection criteria as in
the prospective study. The comparison was
performed with the conventional arm of the
clinical trial [199 cases].
Results of the study: Significant differences
were recorded in the: ? performance status and
in the number of T1 and T3 cases, ? compliance
to protocol in the total dose and the overall
treatment time, ? response to treatment in the
whole group and in the particular stages These
results indicate the very demanding selection of
cases and much more rigorous compliance with
the therapeutic protocol in the prospective study.
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